216 related articles for article (PubMed ID: 36587388)
1. The Role of Nanotechnologies in Brain Tumors.
Caffo M; Caruso G; Curcio A; Laera R; Crisafulli C; Fazzari E; Passalacqua M; Germanò A
Adv Exp Med Biol; 2023; 1394():181-192. PubMed ID: 36587388
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
5. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
6. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
7. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E
Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.
Liu J; Yang F; Hu J; Zhang X
CNS Neurosci Ther; 2024 May; 30(5):e14715. PubMed ID: 38708806
[TBL] [Abstract][Full Text] [Related]
9. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
[TBL] [Abstract][Full Text] [Related]
10. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme.
Sahoo RK; Gupta T; Batheja S; Goyal AK; Gupta U
Curr Drug Metab; 2022; 23(9):708-722. PubMed ID: 35713127
[TBL] [Abstract][Full Text] [Related]
11. Could nanoparticle systems have a role in the treatment of cerebral gliomas?
Caruso G; Caffo M; Alafaci C; Raudino G; Cafarella D; Lucerna S; Salpietro FM; Tomasello F
Nanomedicine; 2011 Dec; 7(6):744-52. PubMed ID: 21419873
[TBL] [Abstract][Full Text] [Related]
12. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.
Huang X; Shi S; Wang H; Zhao T; Wang Y; Huang S; Su Y; Zhao C; Yang M
Int Immunopharmacol; 2023 Apr; 117():109990. PubMed ID: 37012874
[TBL] [Abstract][Full Text] [Related]
13. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment.
Raudino G; Caffo M; Caruso G; Alafaci C; Tomasello F
Recent Pat Nanotechnol; 2011 Nov; 5(3):239-44. PubMed ID: 21871014
[TBL] [Abstract][Full Text] [Related]
15. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
[TBL] [Abstract][Full Text] [Related]
16. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
17. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
19. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
20. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]